FDA Committee Recommends 2022–2023 Influenza Vaccine Strains

The US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee has chosen the influenza vaccine strains for the 2022–2023 season in the northern hemisphere, which beginnings in the fall of 2022. On March 3, the committee unanimously voted to endorse the World Health Organization’s (WHO’s) recommendations as to which influenza […]